AstraZeneca’s anti PD-L1 antibody durvalumab has met the co-primary endpoint in non-small cell lung cancer...
Up To Date
Latest News
Dutch Norgine BV will take-over Merus Labs International Inc. Under the agreement, Norgine will acquire all...
A study conducted by an NIH institute proves Roche’s Avastin is as effective as Regeneron’s Eylea, a drug that...
Fiasco in Phase III: Roche’s conditionally approved PD-L1 checkpoint inhibitor did not meet the endpoint of...
Mucosal inflammation specialist Dermtreat ApS (Copenhagen) has secured a Series A financing worth €16.2m...
GMO world market adoption is further growing. GMO cultivation area in 2016 increased to 185.1 million hectares...